Salvatore Brugaletta Selected Research

Clopidogrel (Plavix)

1/2018	Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study.
1/2018	Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
7/2017	Rationale and design of the Hunting for the off-target propertIes of Ticagrelor on Endothelial function and other Circulating biomarkers in Humans (HI-TECH) trial.
1/2017	Out-of-hospital cardiac arrest and stent thrombosis: Ticagrelor versus clopidogrel in patients with primary percutaneous coronary intervention under mild therapeutic hypothermia.
10/2010	Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) trial substudy.
6/2009	Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Salvatore Brugaletta Research Topics

Disease

57	ST Elevation Myocardial Infarction 08/2022 - 11/2008
51	Thrombosis (Thrombus) 04/2022 - 01/2009
40	Myocardial Infarction 05/2022 - 08/2007
21	Acute Coronary Syndrome 01/2022 - 11/2003
18	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 06/2008
17	Hemorrhage 05/2022 - 09/2010
17	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 11/2008
9	Stroke (Strokes) 05/2022 - 10/2010
9	Death (Near-Death Experience) 01/2021 - 07/2011
7	Diabetes Mellitus 10/2022 - 07/2011
7	Pathologic Constriction (Stenosis) 01/2022 - 03/2012
6	Infarction (Infarctions) 12/2021 - 11/2008
5	Hyperplasia 10/2022 - 02/2011
5	Atrial Fibrillation 10/2021 - 10/2013
5	Neointima 08/2018 - 12/2011
4	Aortic Valve Stenosis (Aortic Stenosis) 05/2022 - 03/2013
4	Atherosclerosis 01/2018 - 10/2009
4	Unstable Angina 09/2009 - 05/2006
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 06/2008
3	Renal Insufficiency (Renal Failure) 07/2018 - 06/2008
2	Non-ST Elevated Myocardial Infarction 01/2022 - 01/2020
2	Aneurysm (Aneurysms) 03/2020 - 03/2014
2	Ischemia 05/2018 - 07/2011
2	Hyperemia 01/2018 - 07/2017
2	Out-of-Hospital Cardiac Arrest 04/2017 - 01/2017
2	Embolism (Embolus) 04/2014 - 10/2013
2	Rupture 01/2014 - 03/2012
2	AIDS-Related Complex (ARC) 10/2013 - 04/2012
2	Atherosclerotic Plaque (Atheroma) 03/2012 - 07/2011
2	Inflammation (Inflammations) 10/2009 - 05/2006
2	Ventricular Remodeling 11/2008 - 08/2007
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2021
1	MINOCA 01/2021
1	Coronary Disease (Coronary Heart Disease) 01/2021
1	Aortic Valve Insufficiency (Aortic Regurgitation) 11/2019
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 04/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Reperfusion Injury 11/2018
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Stable Angina 01/2018
1	Dyspnea (Shortness of Breath) 01/2018
1	Coma (Comas) 01/2017
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2016
1	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2016
1	Left Ventricular Dysfunction 01/2016

Drug/Important Bio-Agent (IBA)

31	Everolimus FDA Link 10/2022 - 12/2011
19	MetalsIBA 01/2021 - 12/2011
12	omega-Chloroacetophenone (Mace)IBA 10/2019 - 06/2009
9	PolymersIBA 12/2021 - 06/2014
7	TicagrelorIBA 01/2020 - 06/2015
6	Sirolimus (Rapamycin)FDA Link 08/2022 - 01/2019
6	bivalirudin (Angiomax)FDA Link 06/2019 - 03/2015
6	Clopidogrel (Plavix)FDA Link 01/2018 - 06/2009
5	Prasugrel Hydrochloride FDA Link 01/2020 - 06/2015
5	C-Reactive ProteinIBA 08/2010 - 11/2003
4	MagnesiumIBA 08/2022 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2003
4	LipidsIBA 12/2021 - 10/2009
4	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2021 - 01/2017
4	Heparin (Liquaemin)FDA LinkGeneric 06/2019 - 02/2015
4	TroponinIBA 01/2018 - 11/2003
3	Glycoproteins (Glycoprotein)IBA 01/2018 - 11/2014
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018 - 06/2009
3	Adenosine (Adenocard)FDA LinkGeneric 01/2018 - 07/2017
3	CobaltIBA 11/2014 - 12/2011
3	ChromiumIBA 11/2014 - 12/2011
2	zotarolimusIBA 01/2022 - 04/2009
2	apixabanIBA 01/2022 - 10/2021
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2014
2	CreatinineIBA 01/2021 - 06/2008
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 12/2011
2	Dihydrotachysterol (AT 10)IBA 05/2012 - 06/2009
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2009 - 11/2008
1	SugarsIBA 01/2022
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 04/2019
1	AntithrombinsIBA 01/2018
1	antineoplaston A10 (A 10)IBA 07/2017

Therapy/Procedure

79	Stents 10/2022 - 01/2009
40	Percutaneous Coronary Intervention 04/2022 - 11/2008
26	Drug-Eluting Stents 04/2022 - 01/2009
15	Therapeutics 01/2022 - 11/2008
5	Transcatheter Aortic Valve Replacement 05/2022 - 03/2013
4	Contraindications 01/2018 - 10/2013
3	Thrombectomy 05/2019 - 01/2016
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2018 - 06/2015
3	Induced Hypothermia 04/2017 - 01/2016
2	Myocardial Revascularization 01/2018 - 07/2011
2	Catheters 12/2015 - 02/2015
1	Length of Stay 05/2022
1	Bioprosthesis 11/2019
1	Decompression 04/2019
1	Protective Devices (Safety Device) 01/2019
1	Extracorporeal Membrane Oxygenation 11/2018
1	Counterpulsation (External Counterpulsation) 11/2018
1	Duration of Therapy 01/2018
1	Punctures 08/2016
1	Glycemic Control 01/2016